Skip to main content

Research Repository

Advanced Search

Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa

Ng, Vivian; Kuehne, Sarah A.; Chan, Weng

Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa Thumbnail


Authors

Vivian Ng

Sarah A. Kuehne



Abstract

Teixobactin, a recently discovered depsipeptide that binds to bacterial lipid II and lipid III, provides a promising molecular scaffold for the design of new antimicrobials. Herein, we describe the synthesis and antimicrobial evaluation of systematically modified teixobactin analogues. The replacement of Ile11 residue with aliphatic isosteres, the modification of the guanidino group at residue 10 and the introduction of a rigidifying residue, dehydroamino acid into the macrocyclic ring generated useful structure‐activity information. Extensive antimicrobial susceptibility assessment against a panel of clinically relevant Staphylococcus aureus and Propionibacterium acnes led to the identification of a new lead compound, [Arg(Me)10,Nle11]teixobactin 63, with excellent bactericidal activity (MIC 2‐4 μg/mL). Significantly, the antimicrobial activity of several of the teixobactin analogues against the pathogenic Gram‐negative Pseudomonas aeruginosa was 'restored' when combined with sub‐MIC concentration of the outer membrane‐disruptive antibiotic, colistin. The antimicrobial effectiveness of [Tfn10,Nle11]teixobactin 66 (32 μg/mL)‐colistin (2 μg/mL; 0.5x MIC) combination against P. aeruginosa PAO1 reveal, for the first time, an alternative therapeutic option in the treatment of Gram‐negative infections.

Citation

Ng, V., Kuehne, S. A., & Chan, W. (in press). Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa. Chemistry - A European Journal, 24(36), 9136-9147. https://doi.org/10.1002/chem.201801423

Journal Article Type Article
Acceptance Date May 9, 2018
Online Publication Date May 9, 2018
Deposit Date May 9, 2018
Publicly Available Date May 10, 2019
Journal Chemistry - a European Journal
Print ISSN 0947-6539
Electronic ISSN 1521-3765
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 24
Issue 36
Pages 9136-9147
DOI https://doi.org/10.1002/chem.201801423
Keywords macrocyclic peptides; lipid II inhibitors; teixobactin;
antimicrobial; colistin
Public URL https://nottingham-repository.worktribe.com/output/931841
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1002/chem.201801423
Additional Information This is the peer reviewed version of the following article: Ng, V., Kuehne, S. and Chan, W. (2018), Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa. Chem. Eur. J.. Accepted Author Manuscript, which has been published in final form at http://dx.doi.org/10.1002/chem.201801423. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Contract Date May 9, 2018

Files





You might also like



Downloadable Citations